Healthline Daily

 The Global veterinary drugs market is projected to reach around US$ 121.2 billion by 2034, up from US$ 53.1 billion in 2024. This represents a strong CAGR of 8.6% from 2025 to 2034. A key factor driving this growth is the rising rate of pet ownership. More people now treat pets as family members, especially in urban areas. As awareness of animal health increases, so does the demand for medicines like antibiotics, vaccines, and pain relievers. This trend is expected to continue, especially in regions where pet care services are becoming more accessible. Another important factor is the increase in animal diseases, including infections, arthritis, and diabetes. The World Organisation for Animal Health (WOAH) emphasizes the importance of monitoring such conditions to protect both animals and humans. Zoonotic diseases, which spread between animals and humans, are also on the rise. This has led to growing demand for effective treatments in clinics, farms, and shelters. The focus on ...

 The Global veterinary dermatology drugs market is projected to grow significantly, reaching approximately US$ 45.2 billion by 2034, up from US$ 17.9 billion in 2024. This reflects a healthy CAGR of 9.7% from 2025 to 2034. In 2024, North America held the largest share, accounting for over 39.2%, driven by high pet ownership and access to advanced veterinary care. One key driver is the increased awareness of skin conditions in pets. Allergies, infections, and chronic issues are now widely recognized by both pet owners and veterinarians, which fuels demand for accurate diagnosis and effective treatment. Advancements in veterinary medicine are also supporting market growth. Modern tools now allow for quick identification of skin problems, while new drug formulations reduce side effects. Additionally, the rising emotional value of pets encourages owners to seek timely care for skin conditions. This trend is further supported by improved veterinary infrastructure, making it easier t...

 The Global RNA-based therapeutics market is projected to reach approximately US$ 41.3 billion by 2034, rising sharply from US$ 8.1 billion in 2024. This growth reflects a strong CAGR of 17.7% from 2025 to 2034. A major factor behind this surge is the urgent need for more effective treatments for complex diseases like cancer, rare genetic conditions, and neurological disorders. Unlike traditional drugs, RNA therapies work at the genetic level, targeting the root cause of disease. This makes them especially valuable for conditions where current treatments fail or have harsh side effects. Another key driver is the advancement in RNA delivery technologies. In earlier years, delivering RNA safely into human cells was a major challenge. However, innovations like lipid-based nanoparticles now protect RNA molecules from degradation and ensure precise targeting. These improvements have significantly boosted treatment outcomes and reduced the risk of adverse effects. In addition, regula...

 The Global immunomodulators market is projected to reach USD 430.6 billion by 2034, growing from USD 229.4 billion in 2024 at a CAGR of 6.5% between 2025 and 2034. North America leads the market with over 39% share, totaling USD 89.5 billion in 2024. A key driver of this growth is the rising prevalence of chronic and immune-related diseases. Conditions like cancer, rheumatoid arthritis, and multiple sclerosis require long-term immune system control. Immunomodulators, especially those using growth factors, help adjust the body’s immune response, making them essential in managing such illnesses. As these conditions increase globally, the demand for advanced immune therapies continues to grow. Scientific progress and technological innovation are also boosting market growth. New treatments are becoming more targeted and personalized, reducing harm to healthy cells. Growth factors are central to these advancements, enabling tailored therapies that match individual patient biology...

The Global biosecurity market is projected to grow from USD 17.45 billion in 2024 to USD 40.93 billion by 2034, at a CAGR of 8.9% during the forecast period. This growth is driven by rising awareness of biological threats and the need for better disease control systems. Outbreaks like COVID-19 and bird flu have shown how fast diseases can spread. As a result, both governments and the public are focusing more on preventing disease transmission at the source—through farms, food systems, and wildlife management. International health agencies like the WHO, FAO, and WOAH are playing a key role in strengthening global health standards. They urge countries to follow unified guidelines for disease prevention, lab safety, and emergency responses. These standards include faster data sharing, infection control, and safer diagnostic procedures. This push is encouraging many countries to upgrade their biosecurity infrastructure and align with global practices. Government support has also increa...

 The U.S. prosthetics and orthotics market is expected to reach USD 2.57 billion by 2024 and grow at a CAGR of 4.9% , reaching USD 4.14 billion by 2034. A key factor driving this growth is the rising prevalence of chronic health conditions. Diseases like diabetes and vascular disorders can lead to limb loss or mobility issues. As a result, there is growing demand for prosthetic limbs and orthotic devices. Government health agencies support early diagnosis and care for such conditions, which encourages the use of mobility aids. Another major contributor is the aging population. As people in the U.S. age, they face health issues such as arthritis, joint pain, and reduced bone density. Many older adults rely on orthotic devices like braces and supports to maintain mobility and prevent injury. Global health bodies recognize aging as a major factor in increasing demand for rehabilitation tools. Prosthetics and orthotics help older individuals remain independent, which further boosts ...

 The U.S. medical billing outsourcing market is projected to grow from USD 6.3 billion in 2024 to USD 19.7 billion by 2034, registering a CAGR of 12.1% during the forecast period. One of the primary drivers of this growth is the rising administrative burden in healthcare. Providers face increased paperwork, insurance claims, and coding responsibilities. These tasks require trained staff and can distract from core clinical care. As a result, many hospitals, clinics, and private practices are outsourcing billing tasks to reduce workload and focus on patient outcomes. The complexity of medical billing and regulatory compliance is also pushing demand for outsourcing. U.S. healthcare providers must follow strict rules, such as those under HIPAA, and navigate ever-changing medical coding systems. Frequent updates in codes and billing standards require deep expertise. Outsourcing to billing companies ensures accuracy, compliance, and faster reimbursement. These specialists are well-ve...

 The U.S. cannabis market is projected to grow from USD 38.4 billion in 2024 to around USD 115.1 billion by 2034, expanding at a CAGR of 11.6% . This growth is driven by policy reforms, expanding healthcare acceptance, and evolving consumer preferences. As more U.S. states adopt cannabis legalization measures, both for medical and recreational use, the legal framework becomes more supportive. Federal efforts to ease cannabis research restrictions are also helping legitimize the industry. These changes are encouraging more businesses to enter the market and making cannabis products safer and easier to access for consumers. Medical acceptance is another key factor. More healthcare providers are recognizing cannabis as a useful option in treatment plans for chronic pain, anxiety, epilepsy, and other conditions. This support is leading to a rise in medical cannabis use, especially among patients who seek alternatives to traditional medicine. At the same time, public opinion is shift...

  Overview 26 June 2025 –The Global Electrical Stimulation Devices Market is projected to grow from USD 6.5 billion in 2023 to USD 10.7 billion by 2033 , at a CAGR of 5.1% . This growth is driven by several key factors. An aging global population is leading to more cases of muscle weakness, joint stiffness, and slower recovery. Electrical stimulation helps manage these age-related issues by improving blood flow and reducing pain. Rising cases of chronic conditions such as stroke, arthritis, and diabetes are also increasing demand for non-invasive therapies. Healthcare systems are shifting toward home-based care. Portable and user-friendly devices support self-managed treatment. Technological advancements—like smart apps and Bluetooth features—make monitoring easier for both patients and doctors. Developing regions are expanding healthcare access, supported by government investments and awareness campaigns. Global health bodies like WHO are also promoting cost-effective, drug-free...

  Overview 26 June 2025 –The Global animal vaccine market is projected to grow from USD 13.6 billion in 2024 to USD 34.6 billion by 2034, with a CAGR of 9.8% . North America leads with over 30.2% market share, valued at USD 4.1 billion in 2024. This growth is driven by rising demand for milk, meat, and eggs, which pushes farmers to invest in animal health. Vaccines help prevent diseases that can impact productivity and food quality. Governments and global health agencies support this through subsidies, vaccination drives, and awareness programs. Preventing zoonotic diseases is also a key focus. Vaccinating animals helps control diseases that can spread to humans. Increased pet ownership further boosts the market, with more people prioritizing preventive care for their pets. Technology is improving vaccine effectiveness and ease of use, including oral and nasal options. Global non-profits also support vaccine access in low-resource areas. These efforts aim to reduce disease out...

  Overview 26 June 2025-The Global burn care market is projected to grow from USD 2.73 billion in 2022 to USD 6.17 billion by 2032, at a CAGR of 8.5% . This growth is driven by rising burn injuries, especially in low- and middle-income countries, where people are exposed to open flames, unsafe cooking, and poor housing. Urban growth and industrial activities are also increasing burn risks. The aging population is another key factor. Older adults have thinner skin and slower healing, creating demand for advanced treatments. Governments are now focusing on specialized care for seniors. Technology is transforming burn care. Advanced dressings, skin substitutes, and bioengineered tissues improve healing and reduce pain. These innovations are often funded by public research programs. There is also a shift toward outpatient and home-based burn care. Public health programs support this trend, helping reduce costs while ensuring quality treatment. In addition, awareness campaigns are pr...

  Overview 26 June 2025 –The Global single-cell multiomics market is projected to grow from USD 2.5 billion in 2023 to USD 17.5 billion by 2033, at a CAGR of 21.5% . This rapid growth is driven by rising demand for precision medicine. Healthcare is shifting from general treatments to personalized care, and single-cell multiomics enables deeper understanding of cell behavior. This leads to more accurate diagnosis and tailored therapies. Government and public health organizations are also supporting this field through funding and research initiatives. These efforts aim to find the root causes of complex diseases and develop better treatments. Large global projects, such as mapping human cell types, are further boosting demand by standardizing research methods. Technological advancements in sequencing and data analysis tools are making single-cell studies faster and easier. This supports wider adoption in labs and hospitals. The increasing burden of chronic and infectious diseases,...

  Overview 25 June 2025 – The Global point-of-care diagnostics market is projected to reach USD 86.2 billion by 2032, growing from USD 40.9 billion in 2022. This growth is expected at a CAGR of 7.95% from 2022 to 2032. One major driver is the rising burden of chronic and infectious diseases. Conditions like diabetes, heart problems, and tuberculosis require quick and accessible testing, especially in rural or underserved areas. Technological advancements are also boosting the market. Modern devices are smaller, more accurate, and easier to use. Mobile apps and handheld tools now allow testing at clinics, homes, or in the field. This supports the growing trend of home-based care and remote health monitoring. Governments worldwide are promoting these tools through national health programs. Policies support testing in schools, maternal care, and community health centers. Many devices now connect with smartphones and digital systems, helping track patient data and speed up diagnosi...

  Overview 25 June 2025– The Global mammography market is projected to reach USD 6,922.7 million by 2033, up from USD 2,742.5 million in 2023. This reflects a strong CAGR of 9.7% from 2024 to 2033. One of the key growth drivers is the increasing awareness of breast cancer. Health campaigns by governments, WHO, and non-profits are encouraging regular screenings. Government support through national programs is also boosting demand. Many countries now offer free or low-cost mammograms, especially to low-income groups. These programs improve access by removing referral barriers. Technological advancements, such as 3D imaging and AI-based systems, are improving the accuracy and comfort of screenings. This encourages greater adoption by both patients and providers. Mobile screening units are expanding access in rural and remote areas. This ensures more equitable healthcare delivery. An ageing population and rising health consciousness are also expanding the target group for mammograp...